Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin

Autor: J. Burggraaf, R. G. M. Van Amsterdam, Rik C. Schoemaker, R.A. Faaij, Adam F. Cohen

Publikováno v: British Journal of Clinical Pharmacology. 54:304-308

Aims To investigate the pharmacokinetic and pharmacodynamic interaction of the antithrombotic pentasaccharide fondaparinux (Org31540/SR90107A), given subcutaneously, and oral warfarin in healthy subjects. Methods This study was performed according to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::98e98bcfff87fda5fcb686fa4f4157a1
https://doi.org/10.1046/j.1365-2125.2002.01616.x

Two New Closely Related Rat Models with Relevance to Arterial Thrombosis – Efficacies of Different Antithrombotic Drugs

Autor: P. Zandberg, W. J. Kop, R. G. M. Van Amsterdam, P. van Houwelingen, G.M.T. Vogel, D.G. Meuleman, F. W. J. Van Mensvoort

Publikováno v: Thrombosis and Haemostasis. 77:183-189

SummaryTwo thrombosis models in rats are described in which mixed type thrombi are formed at arterial and venous flow rates. The models, containing a silk thread in the aorta and vena cava, respectively, were characterised for the activity of three p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::14728923992324131ec0c09e6714a5fa
https://doi.org/10.1055/s-0038-1655928

Synthetic Analogues of the Antithrombin III– Binding Pentasaccharide Sequence of Heparin

Autor: W. J. Kop, D.G. Meuleman, G.M.T. Vogel, M. T. Buiting, R. G. M. Van Amsterdam, A. Visser

Publikováno v: Arteriosclerosis, Thrombosis, and Vascular Biology. 15:495-503

Abstract The synthetic pentasaccharide Org 31540/SR 90107A represents the antithrombin III (ATIII) binding region of heparin and accelerates the ATIII-mediated inhibition of coagulation factor Xa. This compound and 15 structural analogues with ATIII

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d3993ae80b3a7cc1aa9cf42d3404474
https://doi.org/10.1161/01.atv.15.4.495

Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin

Autor: R A, Faaij, J, Burggraaf, R C, Schoemaker, R G M, Van Amsterdam, A F, Cohen

Publikováno v: British journal of clinical pharmacology. 54(3)

To investigate the pharmacokinetic and pharmacodynamic interaction of the antithrombotic pentasaccharide fondaparinux (Org31540/SR90107A), given subcutaneously, and oral warfarin in healthy subjects.This study was performed according to a randomised,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4bcc7fa0e6481f7f312fee6f8f7f20d5
https://pubmed.ncbi.nlm.nih.gov/12236851

Abstracts of papers pharmacological meeting

Autor: G. J. Blauw, P. van Brummelen, P. Vermeij, P. A. van Zvieten, H. W. C. M. Boddeke, H. N. Doods, P. A. van Zwieten, A. H. Bom, D. J. Duncker, P. D. Verdouw, P. R. Saxena, M. J. A. P. Daemen, H. T. M. Vervoort-Peters, H. H. W. Thijssen, D. Davidesko, H. D. Batink, H. D. Bangik, K. J. van Charldrop, S. F. de Boer, J. L. Slangen, J. van der Gugten, W. S. De Loos, B. Bohus, W. De Jong, D. De Wied, M. A. H. de Zwart, H. van der Goot, H. Timmerman, A. Garritsen, A. P. IJzerman, W. Soudijn, J. B. Heynis, H. W. G. M. Boddeke, B. J. A. Janssen, H. van Essen, H. A. J. Struyker Boudier, J. F. M. Smits, T. J. W. Jap, C. E. J. Ketelaars, J. Bruinvels, M. J. Krielaart, D. M. J. Veenstra, G. J. T. H. Stolze, L. M. L. le Noble, D. W. Slaaf, G. J. Tangelder, H. C. Neijt, I. J. te Duits, J. J. Plomp, H. P. M. Vijverberg, J. A. M. Raaijmakers, R. J. E. van den Eijnde, F. S. Radhakishun, J. C. Stoof, A. H. Mulder, D. H. G. Versteeg, J. M. van Ree, F. A. M. Redegeld, J. Noordhoek, J. M. H. M. Reul, J. A. D. M. Tonnaer, E. R. de Kloet, J. Riezebos, A. de Jonge, C. G. J. Sweep, V. M. Wiegant, F. Th. M. van Amsterdam, M. Haas, J. Zaagsma, R. G. M. van Amsterdam, F. Brouwer, K. J. van Charldorp, R. van de Straat, J. de Vries, N. P. E. Vermeulden, P. L. M. van Giersbergen, J van Harten, RRECM Zeegers, P van Brumnelen, DD Breimer, P. N. M. van Heiningen, E. J. van Hoogdalem, A. G. de Boer, D. D. Breimer, J. van Wijngaarden, H. Wesseling

Publikováno v: Pharmaceutisch Weekblad. 8:270-278

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4fba487c10f884e8c4f524c81f871237
https://doi.org/10.1007/bf01960072